OMC
ITCI

Old Mission Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Old Mission Capital’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,118
Closed -$452K – 1285
2021
Q3 		$452K Buy
+12,118
New +$421K 0.02% 611
2021
Q1 		– Sell
-14,570
Closed -$463K – 926
2020
Q4 		$463K Buy
+14,570
New +$383K 0.03% 375

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Old Mission Capital's ITCI Position: Q4 2021 in Review

Old Mission Capital sold out of Intra-Cellular Therapies Inc. (ITCI) in Q4 2021, closing a stake of 12,118 shares — an estimated $452K sold.

Old Mission Capital first reported a position in ITCI in Q4 2020 and held it in 2 quarters. The position peaked at $463K in Q4 2020. 208 funds tracked by Wall St. Rank hold ITCI as of Q4 2021.

  • Old Mission Capital reported no remaining Intra-Cellular Therapies Inc. position as of Q4 2021 after selling out during the quarter.
  • Old Mission Capital sold 12,118 Intra-Cellular Therapies Inc. shares in Q4 2021, an estimated $452K.
  • Old Mission Capital first reported a position in Intra-Cellular Therapies Inc. in Q4 2020 and held it in 2 quarters.
  • Old Mission Capital's Intra-Cellular Therapies Inc. position peaked at $463K in Q4 2020.
  • 208 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2021.

Based on Old Mission Capital's 13F filing for Q4 2021, filed 10 Feb 2022.